Shares of VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) were up 5.9% during trading on Monday . The stock traded as high as C$0.18 and last traded at C$0.18. Approximately 94,860 shares traded hands during mid-day trading, a decline of 67% from the average daily volume of 290,300 shares. The stock had previously closed at C$0.17.
VentriPoint Diagnostics Price Performance
The company has a quick ratio of 6.67, a current ratio of 0.28 and a debt-to-equity ratio of -58.56. The stock’s 50 day moving average price is C$0.10 and its two-hundred day moving average price is C$0.13. The stock has a market cap of C$29.20 million, a price-to-earnings ratio of -5.56 and a beta of 0.39.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
See Also
- Five stocks we like better than VentriPoint Diagnostics
- Dividend Capture Strategy: What You Need to Know
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- The 3 Best Fintech Stocks to Buy Now
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
- Insider Trades May Not Tell You What You Think
- Energy and Basic Materials Sectors Will Dominate in 2025
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
